Xianghui Du, MD
Zhejiang Cancer Hospital
4
2
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ming Chen, PhD
Zhejiang Cancer Hospital
Shared therapeutic areas:
Worked with same sponsors:
weiguo zhu, MD
Huai'an First People's Hospital
Shared therapeutic areas:
Worked with same sponsors:
youngling JI, MD
Zhejiang Cancer Hospital
Shared therapeutic areas:
Worked with same sponsors:
David R. Spigel, MD
SCRI Development Innovations, LLC
Shared therapeutic areas:
Brennan Spiegel, MD, MSHS
Cedars-Sinai Medical Center
Shared therapeutic areas:
John D. Hainsworth, MD
SCRI Development Innovations, LLC
Shared therapeutic areas:
Deborah E Citrin, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Robert L. DeJager, MD, FACP
Daiichi Sankyo
Shared therapeutic areas:
Sachin Wani, MD
University of Colorado, Denver
Shared therapeutic areas:
Xiaoli Lan, PhD
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer
S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer
S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer
A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer
All 4 trials loaded